Patent Number: 7,825,225

Title: Vaccine

Abstract: The invention relates to a vaccine for the treatment of disease caused by Neisseria, the vaccine including one or more immunogenic components for Neisseria serogroups, as well as antibodies to the immunogenic components and methods of preventing and treating Neisseria infections. The immunogens are based on elements of the inner core lipopolysaccharide.

Inventors: Plested; Joyce Susan (Oxford, GB), Jennings; Michael Paul (Queensland, AU), Gidney; Margaret Ann Jaqueline (Ottawa, CA), Cox; Andrew David (Ottawa, CA), Richards; James Clare (Ottawa, CA), Moxon; Edward Richard (Oxford, GB)

Assignee: Isis Innovation Ltd.

International Classification: C12P 21/08 (20060101); A61K 39/40 (20060101); C12N 5/07 (20100101)

Expiration Date: 2019-11-02 0:00:00